SEC Form 4 · accession 0000899243-16-023770
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Renee D Gala
Director
Period of report
Jun 27, 2016
Accepted (ET)
Jun 28, 2016 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.11 | Jun 27, 2016 | A | 70,000 | A | — | Jun 27, 2026 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F1Exercisable on the first annual anniversary of June 27, 2016 with respect to 25% of the total number of option shares, and with respect to an additional 2.08334% of the total number of option shares on each monthly anniversary thereafter.